This was an independent session organised by MGP without financial support or involvement from the pharmaceutical industry.
This site is intended for UK healthcare professionals
Dr Kevin Fernando Q&A on type 2 diabetes
Dr Kevin Fernando answers questions on the impact of type 2 diabetes on patients’ daily lives, differences between NICE and SIGN guidance, and key take-home messages for primary care
Related articles
VideoDr David Unwin Q&A on type 2 diabetes
In this video, taken at Guidelines Live 2019, Dr David Unwin answers questions on dietary management of diabetes and offers his key take-home messages.
- Video
Michelle Lam Q&A on type 2 diabetes
In this video, taken at Guidelines Live 2019, Michelle Lam answers questions about guidance on managing type 2 diabetes, the differences between the guidelines, and her key take-home messages.
- On demand webinars
Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)
This promotional educational webinar has been organised and funded by Takeda UK Ltd. See bottom of page for full disclaimer. View prescribing information Video: DPP-4 inhibitors webinar Click here to complete the feedback and receive your CPD certificate ...
More Videos
- Video
Dr Glenis Scadding Q&A on rhinitis
This session was supported by an educational grant from Mylan Ltd. Dr Glenis Scadding comments on the main presentations of rhinitis, its impact on patients’ daily lives, red flags for referral, and the main recommendations of the 2017 BSACI guideline
- Video
Guidelines Live 2018 overview with Dr Matthew Fay
Dr Matt Fay, Chair of Guidelines Live 2018, provides his thoughts on the programme from a primary care perspective, and summarises the meetings.
No comments yet